The listed company has stated that there is no trading relationship with the involved violation company, and there are no related or cooperative relationships. The semiconductor equipment giant is accelerating its acquisition pace, and a significant deep-sea concept technology stock has released a notice of unusual activity… What announcements are worth paying attention to after today's trading session?
On March 20, at 3:15 PM, Chongqing Baiya Sanitary Products stated that the company has no trading transactions with the implicated violating company, nor does it have any related or collaborative relationships. Semiconductor equipment giant NAURA Technology Group is accelerating the acquisition steps of Kingsemi Co., Ltd., and Shanghai SK Petroleum & Chemical Equipment Corporation, a major deep-sea Concept technology stock, issued a notice of unusual movement, with sales revenue of offshore engineering products being relatively low...
The following are selected post-market announcements:
Chongqing Baiya Sanitary Products: The company has not participated in the irregularities mentioned in the March 15 report.
Chongqing Baiya Sanitary Products published a response announcement to the Shenzhen Stock Exchange's inquiry letter, stating that after investigation, the company was unaware of the reported violations mentioned in the March 15th report and has not participated in such illegal activities. The company has no trading transactions with the implicated violating company and has no relevant relationships or cooperative ties. Since the early morning of March 16, the company has taken over all processing procedures for production defects and has stopped cooperation with professional recycling entities regarding the disposal of waste materials, opting to destroy production defects through eco-friendly incineration and other methods to completely eliminate the possibility of illegal recycling.
NAURA Technology Group plans to bid for 8.41% of Kingsemi Co., Ltd.
NAURA Technology Group announced that the company plans to participate in the bidding for 8.41% of Shenyang Kingsemi Electronics Equipment Co., Ltd., totaling 16.8997 million shares, with a listing price of no less than 85.71 yuan/share, totaling no less than 1.448 billion yuan. The company held a Board of Directors meeting on March 20, 2025, and approved the related proposals, with the trading funds sourced from its own funds. If this bid is successful, combined with the previously planned acquisition of 9.49% of Kingsemi, the company's shareholding ratio in Kingsemi will reach 17.9%. This bidding aims to promote the company's strategy and leverage the synergistic effects in the semiconductor equipment industry.
Shanghai SK Petroleum & Chemical Equipment Corporation: The relatively low sales revenue from offshore engineering products will not have a significant impact on the company's short-term performance.
Shanghai SK Petroleum & Chemical Equipment Corporation has issued an announcement regarding unusual market movements. The company has noticed that there has been increased attention on the "Deep Sea Technology" concept in the market recently. Some models of wellhead, well control equipment, and logging instruments can be used for the exploration and development of offshore Oil & Gas resources, but the sales revenue from related marine engineering products has only accounted for about 5% of the company’s revenue over the past three years, which is relatively low and will not significantly impact the company's short-term performance.
Hainan Airlines Holding: The subsidiary intends to renew the lease for 2 B737-800 aircraft and lease 1 A321NEO aircraft.
Hainan Airlines Holding announces that its holding subsidiary, Xiangpeng Aviation, intends to renew the lease for 2 B737-800 aircraft from Yangtze River No. 79, with a total rent not exceeding 8 million USD; at the same time, it intends to lease 1 A321NEO aircraft from Yangtze River No. 3, with a total rent not exceeding 63 million USD. Yangtze River No. 79 and Yangtze River No. 3 are both related parties of the company, and this transaction constitutes a related party transaction. The transaction has been approved by the Board of Directors and is subject to review by the shareholders' meeting. This transaction is necessary for the company's normal production and operation needs, the transaction price is fair, and it will not adversely affect the company's sustainable operation capability and independence.
Beijing Centergate Technologies: Duoduo Pharmaceutical's hydrochloride bromhexine injection has been accepted by the National Medical Products Administration.
Beijing Centergate Technologies announced that the application for marketing authorization of the hydrochloride bromhexine injection (specification: 2ml:4mg) from its subsidiary, Duoduo Pharmaceutical, has been accepted by the National Medical Products Administration. This Pharmaceutical is used to treat chronic bronchitis and other respiratory diseases in cases where oral administration is difficult.
Canmax Technologies: The subsidiary Yichun Shengyuan has obtained the mining license for the ceramic clay (containing Lithium) in the Jinzifeng-Yifeng County Zuojiali mining area of Fengxin County, Jiangxi.
On March 20, Jinshi Futures reported that Canmax Technologies announced that its subsidiary Yichun Shengyuan Lithium Industry Co., Ltd. has obtained the "Mining License" issued by the Yichun City Natural Resources Bureau for the ceramic clay (containing Lithium) in the Jinzifeng-Yifeng County Zuojiali mining area of Fengxin County, Jiangxi Province. The mine type is ceramic clay, and the mining method is open-pit mining, with a production scale of 9 million tons/year, a mining area of 0.8429 square kilometers, and a validity period of twenty-three years (from March 7, 2025, to March 6, 2048). This matter will help the company increase its Lithium mineral resource reserves, ensure resource supply, and enhance its core competitiveness. However, the company has not yet conducted comprehensive mining in the mining area, and there is a risk of discrepancies between forecasts and actual mining.
Huangshan Novel: In 2024, the Net income is 0.468 billion yuan, an increase of 14.63% year-on-year.
Huangshan Novel announced that in 2024, the revenue is 3.525 billion yuan, an increase of 4.34% year-on-year. The Net income attributable to Shareholders of the listed company is 0.468 billion yuan, an increase of 14.63% year-on-year. The basic EPS is 0.76 yuan/share, an increase of 13.43% year-on-year. The company intends to distribute a cash dividend of 6.2 yuan (including tax) for every 10 shares to all Shareholders, with 0 bonus shares (including tax), without converting the surplus fund into share capital.
Yingfeng Co., Ltd.: Plans to repurchase shares for 60 million yuan - -0.12 billion yuan.
Yingfeng Co. announced that the company plans to repurchase shares with funds of 60 million yuan to -0.12 billion yuan, with a repurchase price not exceeding 8 yuan per share. All repurchased shares will be used for the implementation of the employee stock ownership plan or Stock-based Incentive plan, with an estimated repurchased quantity of 7.5 million to -15 million shares, accounting for 1.70% to 3.41% of the company's total share capital.
Zhejiang Conba Pharmaceutical: The actual controller will change to the couple Li Hongming and Wang Xuefang. Stocks will resume trading tomorrow.
Zhejiang Conba Pharmaceutical announced that its controlling shareholder, Shaanxi Kanghui Holding Co., Ltd., signed a share transfer agreement on the same day with Jiaxing Yuehe Zhichuang Technology Partnership (Limited Partnership). Kanghui Holding intends to transfer 21.9736 million shares (accounting for 22% of the total shares of the company) to Yuehe Zhichuang at a transfer price of 24.7 yuan per share, with a total price of 0.543 billion yuan. If the transaction is successfully completed, the controlling shareholder of the company will change from Kanghui Holding to Yuehe Zhichuang, and the actual controller will change from Wang Yanling to the couple Li Hongming and Wang Xuefang. The company’s stocks will resume trading on March 21.
Guoguang Electric: Vice President Li Jing resigns.
Guoguang Electric announced that the Board of Directors has received the resignation letter from Vice President Li Jing, who resigns from the position of Vice President and other roles for personal reasons. After resigning, Li Jing will no longer hold any position in the company and does not Hold any company Stocks.
Farasis Energy: Received the designated development notification from Xiaopeng Huitian.
Farasis Energy announced that the company recently received a designated development notification from Guangdong Huitian Aviation Hi-Tech Holding Group Co., Ltd. Xiaopeng Huitian has decided to choose the company as the supplier of high-pressure power Battery, high-pressure connectors, and low-pressure connectors for its next-generation prototype. Receiving this designated development notification is an important achievement from the company's years of layout in the low-altitude economy field, which will help the company consolidate its competitive position in related fields and inject new动力 into the company's future growth.
Ningbo Donly has seen four consecutive limit ups: The company currently has no Siasun Robot&Automation related products or performance.
Ningbo Donly issued an announcement regarding abnormal stock trading fluctuations stating that the company currently has no products or performance related to Siasun Robot&Automation, which will not have a significant impact on the company's normal business activities and does not constitute a significant impact on the company's current performance and financial status, nor is there any situation that would harm the interests of the company and all shareholders.
SKSHU Paint received a government subsidy related to revenue of 48.4385 million yuan.
SKSHU Paint announced in the evening that its wholly-owned subsidiary, Anhui SKSHU Paint Co., Ltd., received a government subsidy related to revenue of 48.4385 million yuan, accounting for 27.91% of the company's most recent audited Net income.
In the last three days, Jiangsu Yawei Machine Tool has seen two circuit breakers: the company currently has no controlling shareholder and actual controller.
Jiangsu Yawei Machine Tool announced that the company's stock trading price has consecutively deviated from the closing price increase of over 20% for three trading days, which constitutes an abnormal fluctuation. After self-examination, the company found no violations of information fair disclosure. The company's main business includes Metal forming machine tools, laser processing equipment, and Intelligent Manufacturing solutions. The disclosure date for the company's 2024 annual report is April 28, 2025, with no requirements to disclose performance forecasts; there is no situation where undisclosed 2024 performance information has been provided to third parties other than the accounting firm auditing the company. The company currently has no controlling shareholders or actual controllers.
Dongzhu Ecological Environment Protection stated that the company does not have a controlling relationship with Dilos and currently has no substantial business cooperation with them.
Dongzhu Ecological Environment Protection issued a notice of abnormal fluctuations in Stocks Trade, the company has noted recent market reports regarding its affiliated subsidiary, Delos AI Technology (SiChuan) Co., Ltd. (hereinafter referred to as "Delos"). The company holds only a 10% stake in Delos, does not have a controlling relationship with Delos, and currently has no substantial Business cooperation with it. Additionally, Delos was established in January 2025, is still in the startup phase, and has not yet commenced operations; therefore, its future operating performance remains uncertain. The company kindly reminds investors to be aware of the trading risks in the secondary market, make rational decisions, and invest prudently.
CHINA MOBILE: The company expects the total capital expenditure to be approximately 151.2 billion yuan by 2025, mainly for computing power infrastructure upgrades and other purposes.
CHINA MOBILE announced that according to its 2024 annual report, the total capital expenditure for the company in 2024 is approximately 164 billion yuan. For 2025, the company expects a total capital expenditure of approximately 151.2 billion yuan, mainly for optimizing connection infrastructure, upgrading computing power infrastructure, planning for long-term infrastructure layout, and supporting CHBN technology innovation and perception enhancement, with the required funds mainly coming from operating cash flow.
CRRC Corporation: President Ma Yunduo resigns.
CRRC Corporation announced that on March 20, 2025, the company's Board of Directors received the resignation letter of Executive Director and President Ma Yunduo. Mr. Ma Yunduo resigned from the positions of Executive Director, President, member of the Board of Directors' Global Strategy and Sustainable Development Committee, and member of the Nomination Committee due to work adjustments. At the same time, he also resigned from the position of authorized representative of the company under the Hong Kong Exchange Listing Rules. After resigning, Mr. Ma Yunduo will not hold any position in the company or its holding subsidiaries.
China National Chemical Engineering: The contract amount from January to February is 53.42 billion yuan.
China National Chemical Engineering announced that the contract amount for the company from January to February 2025 is 53.42 billion yuan. Among them, the contract amount for Architecture Engineering is 51.47 billion yuan, the contract amount for surveying, design, supervision, and consulting is 0.326 billion yuan, the contract amount for industry and New Materials sales is 1.518 billion yuan, and the contract amount for modern service industry is 0.106 billion yuan. The domestic contract amount is 40.536 billion yuan, and the overseas contract amount is 12.884 billion yuan.
Ye Chiu Metal Recycling: The company's overseas subsidiary has been asked to make up for tax concessions.
Ye Chiu Metal Recycling announced this evening that its overseas subsidiary, YCTL, received a notice from the Malaysian tax bureau regarding the repayment of tax incentives. The Malaysian tax bureau requires YCTL to repay a total of 27.9434 million ringgit (approximately 48.5 million yuan) for the incentives enjoyed in 2018 and 2020, along with the corresponding late fees. The company still has disputes with the tax bureau regarding the specific identification of this matter, and both parties are currently engaged in active communication and negotiation. The final repayment amount and deadline will depend on the tax bureau's final ruling. This matter will not have a significant adverse impact on the company's business operations.
Minsheng Health: Plans to repurchase 0.36%-0.41% of the company's total share capital.
Minsheng Health announced that the company intends to repurchase its already issued unrestricted ordinary shares (A-shares) for the purpose of stock-based incentives. The repurchase price will not exceed 19.80 yuan per share, with the expected number of shares to be repurchased between 1.3 million to -1.45 million shares, accounting for 0.36%-0.41% of the company's current total share capital, with the total amount of funds for the repurchase not exceeding 28.71 million yuan. The repurchase period is within 12 months from the date the Board of Directors approves the repurchase plan.
Hengtong Optic-Electric: Recently won a bid for a 1.133 billion yuan marine Energy project.
Hengtong Optic-Electric announced that the company and its holding subsidiaries recently received project 'Bid Notification' or signed project contracts, confirming the winning bid for domestic and international marine Energy projects, with a total bid amount of 1.133 billion yuan. The projects include the procurement of submarine cables, procurement of cables and accessories, Construction and laying, Ship leasing, marine pipes, and static flexible pipes. The performance of the project contracts is expected to have a positive impact on the company's future Operation performance, and the bid amount accounts for 2.38% of the company's audited revenue for 2023.
2 consecutive boards of Xuchang Yuandong Drive Shaft: the company does not violate fair information disclosure.
Xuchang Yuandong Drive Shaft issued an announcement regarding abnormal fluctuations in stock trading, stating that the company's current production and operation situation is normal and there have been no significant changes in the internal and external business environment. After self-inspection, the company confirms that it does not violate any fair information disclosure obligations. The pre-disclosure date for the company's 2024 annual report is April 9, 2025, and there are no situations that require performance forecasts to be disclosed; there are no undisclosed 2024 performance information provided to any third party other than the accounting firm auditing the company.
JUNSHI BIO: The clinical trial application for injectable JS212 has been approved.
JUNSHI BIO announced that the company has received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, and the clinical trial application for injectable JS212 has been approved.
Zhejiang Conba Pharmaceutical: The subsidiary's acetylcysteine solution has been approved by the FDA in the USA.
Zhejiang Conba Pharmaceutical announced that its wholly-owned subsidiary Zhejiang Jinhua Conba Pharmaceutical Co., Ltd., has received notice from its wholly-owned subsidiary Conba USA Inc in the USA that the New Drug Application (ANDA) submitted to the FDA for acetylcysteine solution has been approved.
Sunflower Pharmaceutical Group: Appoint Yang Yang and Liu Guo Tao as the company's Deputy General Managers.
Sunflower Pharmaceutical Group announced on March 20 that, based on the nomination of the General Manager (President) of the company, the fifth Board of Directors' Nomination Committee and Compensation and Assessment Committee reviewed and the Board of Directors approved it, the company decided to appoint Yang Yang and Liu Guo Tao as the Deputy General Managers of the company, with a term from the date of approval by the Board of Directors until the end of the current Board of Directors' term.
Guangdong Hongda: The head of the internal audit department, Hu Yanyan, resigned due to work adjustments.
Guangdong Hongda announced that the Board of Directors recently received a written resignation report from Hu Yanyan, the head of the internal audit department. Hu Yanyan applied to resign from the position due to work adjustments and will continue to hold other positions in a subsidiary company after resigning. According to relevant regulations, Hu Yanyan's resignation report will take effect from the date it is delivered to the Board of Directors, and the resignation will not have a significant impact on the company’s daily operations. The company will complete the appointment of a new head of the internal audit department as soon as possible.
Yonghui Superstores: The Board of Directors has authorized the reform leadership team to act on behalf of the CEO.
Yonghui Superstores announced that, since the sixth Board of Directors has not yet appointed a CEO, the Board of Directors has authorized the company's reform leadership team to act on behalf of the CEO to ensure that the company's operations and daily management matters proceed smoothly. The company will complete the selection of the CEO as soon as possible.
Pingao Co., Ltd.: Guangzhou Xusheng terminates the Shareholding plan early.
Pingao Co., Ltd. announced in the evening that Guangzhou Xusheng Enterprise Management Consulting Company (Limited Partnership), a shareholder holding 3.78%, originally planned to reduce its holdings of the company by no more than 1.89% through block trading. As of March 20, 2025, Guangzhou Xusheng has cumulatively reduced its holdings of the company by 1% through block trading. Considering the current market environment and its own operational funding arrangements, and based on confidence in the company's future development prospects and recognition of the company's value, Guangzhou Xusheng has decided to terminate this Shareholding plan early.
Winner Medical: Did not participate in the media reports of illegal business.
Winner Medical announced that the company recently received a letter of concern from the Shenzhen Stock Exchange, requesting a self-examination regarding the matters related to the All Cotton Times sanitary products mentioned in the media report. The company quickly established a special team to conduct a comprehensive self-examination and cooperate with the market supervision management department's investigation, and has reported to the public security authorities. The self-examination results show that the company did not participate in the illegal business mentioned in the report and has no transactions or cooperation with the companies involved. In addition, the company implements strict internal control systems in raw material procurement and defective product disposal, and no instances of purchasing unqualified raw materials or the circulation of defective products have been found. The company promises to take measures to improve management systems and strengthen control of defective products to protect consumer interests.
Comment(0)
Reason For Report